US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lonza Group AG

71.34

+1.241.77%

Volume:8.07K

Turnover:571.03K

Market Cap:51.53B

PE:80.91

High:71.47

Open:70.27

Low:70.27

Close:70.10

Loading ...

Overview Company News Filings

Berenberg Bank Keeps Their Buy Rating on Lonza Group (LZAGY)

Lonza price target lowered to CHF 670 from CHF 710 at Barclays

Lonza Group (LZAGY) Upgraded to Buy: Here's What You Should Know

Lonza price target raised to CHF 710 from CHF 630 at Barclays

Lonza price target raised to CHF 680 from CHF 640 at Berenberg

Lonza Group Ltd (LZAGF) (FY 2024) Earnings Call Highlights: Steady Revenue and Strategic Growth ...

Rapid Micro Biosystems announces QC solution collaboration with Lonza

Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology

Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology

NVST or LZAGY: Which Is the Better Value Stock Right Now?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LZAGY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LZAGY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LZAGY\",,,,,undefined,":{"symbol":"LZAGY","market":"US","secType":"STK","nameCN":"Lonza Group AG","latestPrice":71.34,"timestamp":1752686940000,"preClose":70.1,"halted":0,"volume":8068,"delay":15,"floatShares":721849717,"shares":722261840,"eps":0.881668,"marketStatus":"Trading","change":1.24,"latestTime":"07-16 13:29:00 EDT Delay","open":70.27,"high":71.47,"low":70.27,"amount":571027.4241000001,"amplitude":0.017118,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.881668,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1752696000000},"marketStatusCode":2,"adr":0,"adrRate":0.1,"exchange":"PINK LIMITED","adjPreClose":70.1,"volumeRatio":0.193419},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LZAGY\",,,,,undefined,":{"symbol":"LZAGY","floatShares":721849717,"roa":"4.14%","roe":"6.74%","lyrEps":1.054817,"volumeRatio":0.193419,"shares":722261840,"dividePrice":0.4777,"high":71.47,"amplitude":0.017118,"preClose":70.1,"low":70.27,"week52Low":55.57,"pbRate":"4.42","psRate":"6.27","week52High":73.29,"institutionHeld":0,"latestPrice":71.34,"eps":0.881668,"divideRate":0.006696,"volume":8068,"delay":15,"ttmEps":0.881668,"open":70.27,"prevYearClose":58.78,"prevWeekClose":70.72,"prevMonthClose":71.36,"prevQuarterClose":71.36,"fiveDayClose":70.94,"twentyDayClose":69.32,"sixtyDayClose":65.66,"earningDate":1753200000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LZAGY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2546267337","title":"Berenberg Bank Keeps Their Buy Rating on Lonza Group (LZAGY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2546267337","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546267337?lang=en_us&edition=fundamental","pubTime":"2025-06-25 13:35","pubTimestamp":1750829720,"startTime":"0","endTime":"0","summary":"Berenberg Bank analyst Sebastian Bray maintained a Buy rating on Lonza Group (LZAGY – Research Report) yesterday and set a price target of $84.00. ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/berenberg-bank-keeps-their-buy-rating-on-lonza-group-lzagy-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/berenberg-bank-keeps-their-buy-rating-on-lonza-group-lzagy-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Berenberg Bank Keeps Their Buy Rating on Lonza Group (LZAGY)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LZAGY"],"gpt_icon":0},{"id":"2528275047","title":"Lonza price target lowered to CHF 670 from CHF 710 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2528275047","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528275047?lang=en_us&edition=fundamental","pubTime":"2025-04-17 02:06","pubTimestamp":1744826792,"startTime":"0","endTime":"0","summary":"Barclays analyst Charles Pitman lowered the firm’s price target on Lonza (LZAGY) to CHF 670 from CHF 710 and keeps an Overweight rating on the shar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lonza-price-target-lowered-to-chf-670-from-chf-710-at-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lonza-price-target-lowered-to-chf-670-from-chf-710-at-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LZAGY"],"gpt_icon":0},{"id":"2526921846","title":"Lonza Group (LZAGY) Upgraded to Buy: Here's What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2526921846","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526921846?lang=en_us&edition=fundamental","pubTime":"2025-04-09 00:00","pubTimestamp":1744128010,"startTime":"0","endTime":"0","summary":"Lonza Group Ag  could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 . This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.Therefore, the Zacks rating upgrade for Lonza Group basically reflects positivity about its earnings outlook that could translate into buying pressure and an i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lonza-group-lzagy-upgraded-buy-160010575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LZAGY","LZAGF"],"gpt_icon":0},{"id":"2508127533","title":"Lonza price target raised to CHF 710 from CHF 630 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2508127533","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508127533?lang=en_us&edition=fundamental","pubTime":"2025-02-04 03:55","pubTimestamp":1738612553,"startTime":"0","endTime":"0","summary":"Barclays raised the firm’s price target on Lonza (LZAGY) to CHF 710 from CHF 630 and keeps an Overweight rating on the shares. Published first on T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lonza-price-target-raised-to-chf-710-from-chf-630-at-barclays?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lonza-price-target-raised-to-chf-710-from-chf-630-at-barclays?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LZAGY"],"gpt_icon":0},{"id":"2508919799","title":"Lonza price target raised to CHF 680 from CHF 640 at Berenberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2508919799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508919799?lang=en_us&edition=fundamental","pubTime":"2025-02-01 03:35","pubTimestamp":1738352110,"startTime":"0","endTime":"0","summary":"Berenberg analyst Sebastian Bray raised the firm’s price target on Lonza (LZAGY) to CHF 680 from CHF 640 and keeps a Buy rating on the shares. Publ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lonza-price-target-raised-to-chf-680-from-chf-640-at-berenberg?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lonza-price-target-raised-to-chf-680-from-chf-640-at-berenberg?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","LZAGY"],"gpt_icon":0},{"id":"2507393926","title":"Lonza Group Ltd (LZAGF) (FY 2024) Earnings Call Highlights: Steady Revenue and Strategic Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2507393926","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507393926?lang=en_us&edition=fundamental","pubTime":"2025-01-31 15:15","pubTimestamp":1738307707,"startTime":"0","endTime":"0","summary":"Revenue: CHF6.6 billion for the full year 2024, in line with prior year.CapEx: 22% of revenues, focused on organic growth investments.Cash Flow: Strong cash flow of CHF470 million.Biologics Growth: 13% growth excluding mRNA business impact.Cell & Gene Growth: 10% growth adjusted for Kodiak termination.Capsules & Health Ingredients Decline: 6.6% decline in constant currency.Free Cash Flow: CHF500 million, representing 21% of sales before gross CapEx.Dividend Proposal: CHF4 per share, representing a 44% payout.2025 CDMO Outlook: Revenue growth approaching 20%, core EBITDA margin approaching 30%.2025 CHI Outlook: Low to mid single-digit sales growth, EBITDA margin in the mid 20s.GuruFocus has detected 7 Warning Signs with LZAGF.Lonza Group Ltd  reported strong revenue growth in its CDMO business, with growth in the low 10s, adjusted for the extraordinary high base in 2023.Q: Can you provide more color on the seasonality and contribution from mammalian ramp-up in H1 2025?A: Wolfgang Wienan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lonza-group-ltd-lzagf-fy-071507930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LZAGF","LZAGY"],"gpt_icon":0},{"id":"2503682861","title":"Rapid Micro Biosystems announces QC solution collaboration with Lonza","url":"https://stock-news.laohu8.com/highlight/detail?id=2503682861","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503682861?lang=en_us&edition=fundamental","pubTime":"2025-01-15 05:25","pubTimestamp":1736889939,"startTime":"0","endTime":"0","summary":"Rapid Micro Biosystems (RPID) announced a collaboration with Lonza (LZAGY) integrating the Growth Direct and Lonza’s MODA-EM module, creating the f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapid-micro-biosystems-announces-qc-solution-collaboration-with-lonza?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapid-micro-biosystems-announces-qc-solution-collaboration-with-lonza?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4121","LZAGY","RPID"],"gpt_icon":0},{"id":"2502701176","title":"Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2502701176","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502701176?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:00","pubTimestamp":1736427600,"startTime":"0","endTime":"0","summary":"AMSTERDAM, BASEL, Switzerland and INGELHEIM, Germany, Jan. 9, 2025 /PRNewswire/ --Boehringer Ingelheim and Synaffix B.V. , a Lonza company  focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug conjugates , today announced that Boehringer has licensed Synaffix's ADC technology. This new partnership significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company's aim of transforming the lives of people with cancer.ADCs are a cutting-edge class of cancer treatments that combine the targeting ability of antibodies with the potent cancer-killing power of drugs. This allows for the precise delivery of therapeutic agents directly to cancer cells, minimizing damage to healthy tissue and enhancing treatment efficacy.Peter van de Sande, Head of Synaffix, said:\"Boehringer Ingelheim is a leader in oncology treatment development, and the selection of our ADC technologies to further","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/boehringer-ingelheim-broadens-oncology-portfolio-130000913.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/boehringer-ingelheim-broadens-oncology-portfolio-130000913.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LZAGF","BK4231","ADC","LZAGY","BK4121","BK4080"],"gpt_icon":0},{"id":"2502115740","title":"Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2502115740","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502115740?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:00","pubTimestamp":1736427600,"startTime":"0","endTime":"0","summary":"License agreement centered around development of a single ADC program. Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement. AMSTERDAM, Jan. 9, 2025 /PRNewswire/ -- Synaffix B.V. , a Lonza company  focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates  with best-in-class therapeutic index, today announced that it has licensed its ADC technology to Mitsubishi Tanabe Pharma Corporation , the pharma arm of Mitsubishi Chemical Group .Synaffix is responsible for the manufacturing of the components that are related to its proprietary technologies, and MTPC is responsible for the research, development, manufacturing and commercialization of the ADC.Peter van de Sande, Head of Synaffix, said:\"This latest licensing deal with MTPC highlights the appeal of our industry-leading ADC technology offering. MTPC is a key collaborator for us, expanding our presence in the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_sg","url":"https://finance.yahoo.com/news/synaffix-mitsubishi-tanabe-pharma-sign-130000514.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/synaffix-mitsubishi-tanabe-pharma-sign-130000514.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_sg","symbols":["BK6506","BK4080","LZAGY","BK4231","O6Z.SI","ADC","LZAGF"],"gpt_icon":0},{"id":"2500993735","title":"NVST or LZAGY: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2500993735","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500993735?lang=en_us&edition=fundamental","pubTime":"2025-01-02 00:40","pubTimestamp":1735749615,"startTime":"0","endTime":"0","summary":"Investors interested in stocks from the Medical - Products sector have probably already heard of Envista  and Lonza Group Ag . But which of these two stocks presents investors with the better value opportunity right now?The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.Currently, Envista has a Zacks Rank of #2 , while Lonza Group Ag has a Zacks Rank of #5 . Investors should feel comfortable knowing that NVST likely has seen a stronger improvement to its earnings outlook than LZAGY has recently. However, value investors will care about much more than just this.Lonza Group Ag  : Free Stock Analysis Report. To read this article on Zacks.com click here.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nvst-lzagy-better-value-stock-164015257.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0130518102.USD","LU0130103400.USD","LU0477156797.USD","BK4082","LU1201861165.SGD","LZAGF","NVST","LU0648000940.SGD","BK4121","LZAGY"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LZAGY\",params:#limit:5,,,undefined,":[{"date":"2025-05-14","symbol":"LZAGY","amount":0.468284,"announcedDate":"2025-04-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-14","defaultRemindTime":1747229400000,"name":"Lonza Group AG","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-30","payableDate":"2025-05-14","currency":"USD","dateTimestamp":1747195200000,"payDate":"2025-05-30"},{"date":"2024-07-25","symbol":"LZAGY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1721894400000,"name":null,"time":"","dateTimestamp":1721880000000,"actualEps":null},{"date":"2024-05-15","symbol":"LZAGY","amount":0.4417,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-05-16","defaultRemindTime":1715779800000,"name":"Lonza Group AG","recordDate":"2024-05-29","payableDate":"2024-05-16","currency":"USD","dateTimestamp":1715745600000,"payDate":"2024-05-29"},{"date":"2024-05-14","symbol":"LZAGY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715673600000,"name":null,"time":"Pre-Market","dateTimestamp":1715659200000,"actualEps":null},{"date":"2023-07-21","symbol":"LZAGY","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1689926400000,"name":null,"time":"","dateTimestamp":1689912000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LZAGY\",market:\"US\",,,undefined,":[{"executeDate":"2016-04-25","recordDate":"2016-04-27","paymentDate":"2016-05-13","value":0.226781,"currency":"USD"},{"executeDate":"2019-04-24","recordDate":"2019-04-25","paymentDate":"2019-05-13","value":0.242097,"currency":"USD"},{"executeDate":"2020-05-01","recordDate":"2020-05-04","paymentDate":"2020-05-20","value":0.124845,"currency":"USD"},{"executeDate":"2021-05-10","recordDate":"2021-05-11","paymentDate":"2021-05-27","value":0.143947,"currency":"USD"},{"executeDate":"2022-05-09","recordDate":"2022-05-10","paymentDate":"2022-05-26","value":0.312858,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LZAGY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1711080000000}}}